QDX™ HealthID to Support Saliva/Sputum-based COVID-19 Diagnostic Services Developed by MicroGenDX

Tags: Ecosystem

QDX HealthID Incorporated, a wholly-owned subsidiary of Quantum Materials Corp today announced that its parent has signed an agreement to include MicroGenDX diagnostic services as part of the QDX™ HealthID ecosystem. The QDX HealthID, currently in beta release, is a SaaS-based platform that allows companies and individuals to see and select a particular COVID-19 test kit, authenticate and record the test results in a secure way, and then share those authenticated results with friends, family—or any other third party of their choosing.
 
Read the full press release here